Phosphodiesterase-9 as a novel target to treat pulmonary arterial hypertension?

被引：0

作者：

Zhang, L. ^{[1
]}

Bouadjel, K. ^{[1
]}

Wang, L. ^{[1
]}

Mercier, O. ^{[2
,3
]}

Antigny, F. ^{[2
]}

Perros, F. ^{[2
]}

Fischmeister, R. ^{[1
]}

Leblais, V. ^{[1
]}

Manoury, B. ^{[1
]}

机构：

[1] Univ Paris Saclay, Univ Paris Sud, INSERM, UMR S 1180, Chatenay Malabry, France

[2] Univ Paris Saclay, Univ Paris Sud, INSERM, UMR S 999, Le Plessis Robinson, France

[3] Ctr Chirurg Marie Lannelongue, Serv Chirurg Thorac, Le Plessis Robinson, France

来源：

FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2019年 / 33卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PM1-030

引用

页码：30 / 30

页数：1

共 1 条

[1] Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease [J].

Lee, Dong I. ;

Zhu, Guangshuo ;

Sasaki, Takashi ;

Cho, Gun-Sik ;

Hamdani, Nazha ;

Holewinski, Ronald ;

Jo, Su-Hyun ;

Danner, Thomas ;

Zhang, Manling ;

Rainer, Peter P. ;

Bedja, Djahida ;

Kirk, Jonathan A. ;

Ranek, Mark J. ;

Dostmann, Wolfgang R. ;

Kwon, Chulan ;

Margulies, Kenneth B. ;

Van Eyk, Jennifer E. ;

Paulus, Walter J. ;

Takimoto, Eiki ;

Kass, David A. .

NATURE, 2015, 519 (7544) :472-+

← 1 →